levonorgestrel has been researched along with Carcinoma, Endometrioid in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 14 (53.85) | 24.3611 |
| 2020's | 10 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Arencibia Sánchez, O; Bataller, Á; Cabrera, S; Corbalán, S; Coronado, P; Domingo, J; Domingo, S; Espinosa, E; Fiol, G; Gil-Ibañez, B; Gil-Moreno, A; Iacoponi, S; Lago, V; Laseca Modrego, M; Marina, T; Martín Salamanca, B; Minig, L; Munmanny, M; Padilla-Iserte, P; Rodriguez, JR; Sala Ferichola, M; Utrilla-Layna, J | 1 |
| Jiang, J; Li, X; Peng, H | 1 |
| Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F | 1 |
| Deng, C; Gu, Y; Jin, Y; Li, Y; Pan, L; Wang, H; Wang, W; Yin, J | 1 |
| Dong, Z; Guo, W; Ma, C; Pan, N; Wei, H; Xiong, G; Zhang, W | 1 |
| Ma, C; Pan, N; Wang, Y; Wei, H | 1 |
| Bodurka, DC; Broaddus, RR; Burzawa, JK; Coleman, RL; Fellman, B; Fleming, ND; Lu, KH; Milbourne, AM; Nick, AM; Pal, N; Ramondetta, LM; Schmeler, KM; Soliman, PT; Sun, CC; Urbauer, DL; Westin, SN; Woodall, ML; Yates, MS; Yuan, Y | 1 |
| Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
| Andreeva, YY; Krasnopolskaya, KV; Nosov, VB; Novikova, EG; Novikova, OV; Panov, VA; Shevchuk, AS | 1 |
| Chae, SH; Han, ES; Kang, SB; Kim, TJ; Lee, JY; Lee, SJ; Shim, SH; So, KA | 1 |
| Bae, HS; Hwang, JY; Jung, YW; Kim, DH; Kim, MK; Kim, ML; Seong, SJ; Shin, E; Yun, BS | 1 |
| Cao, D; Lang, J; Shen, K; Yang, J; Zhou, H | 1 |
| Dundr, P; Fanta, M; Koliba, P; Kuzel, D; Mara, M; Zizka, Z | 1 |
| Bae, DS; Kang, SB; Kim, JW; Kim, MK; Kim, S; Lee, TS; Lim, MC; Nam, JH; Paek, J; Seong, SJ | 1 |
| Bogani, G; Chiappa, V; Ditto, A; Dondi, G; Evangelista, MT; Ferrero, S; Leone Roberti Maggiore, U; Liberale, V; Martinelli, F; Raspagliesi, F | 1 |
| Casadio, P; Guasina, F; Magnarelli, G; Morra, C; Paradisi, R; Seracchioli, R; Talamo, MR | 1 |
| Jun, HS; Kim, MK; Kim, ML; Kim, YS; Lee, YH; Seong, SJ; Song, T; Yoon, BS | 1 |
| Schorge, JO | 1 |
| Jóźwik, M; Modzelewska, B; Niewińska, M | 1 |
| Hanna, LS; van der Meer, AC | 1 |
| Briggs, P; Thomas, M | 1 |
| Amant, F; Moerman, P; Van Eygen, K; Vandenput, I; Vergote, I | 1 |
| Beiner, M; Ben-Baruch, G; Ferenczy, A; Friedman, E; Gotlieb, WH; Korach, J; Meirow, D; Perri, T | 1 |
| Chung, HH; Kang, SB; Kim, JW; Kim, MK; Park, H; Seong, SJ; Yoon, BS | 1 |
| Gelli, MC; La Sala, GB; Mandato, VD; Nucera, G; Palomba, S | 1 |
| Dhar, KK; Koslowski, M; NeedhiRajan, T; Woolas, RP | 1 |
6 review(s) available for levonorgestrel and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Progestins; Tumor Suppressor Protein p53 | 2022 |
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin | 2022 |
Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis.
Topics: Carcinoma, Endometrioid; Child, Preschool; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy | 2023 |
[Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women].
Topics: Adenocarcinoma; Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Evidence-Based Medicine; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2015 |
Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Levonorgestrel; Prognosis; Treatment Failure | 2009 |
Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Drug Administration Routes; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Uterus | 2005 |
3 trial(s) available for levonorgestrel and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Aldehyde Dehydrogenase 1 Family; Biomarkers; Biomarkers, Tumor; Body Mass Index; Carcinoma, Endometrioid; Contraceptive Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gene Expression; Humans; Intercellular Signaling Peptides and Proteins; Intrauterine Devices, Medicated; Ki-67 Antigen; Levonorgestrel; Membrane Proteins; Middle Aged; Neoplasm Grading; Neoplasm Staging; Quality of Life; Receptors, Cell Surface; Retinal Dehydrogenase; Treatment Outcome; Wnt Signaling Pathway; Young Adult | 2021 |
Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Biopsy, Needle; Carcinoma, Endometrioid; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Prospective Studies | 2019 |
Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study.
Topics: Adult; Age Factors; Algorithms; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Endometrial Neoplasms; Feasibility Studies; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Pilot Projects | 2011 |
17 other study(ies) available for levonorgestrel and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG).
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Spain | 2022 |
Clinical outcomes of levonorgestrel-releasing intrauterine device present during controlled ovarian stimulation in patients with early stage endometrioid adenocarcinoma and atypical endometrial hyperplasia after fertility-sparing treatments: 10-year exper
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovulation Induction; Pregnancy; Retrospective Studies; Tertiary Care Centers | 2023 |
Segmented in vitro fertilization and frozen embryo transfer in levonorgestrel-releasing intrauterine device treated patients with endometrial cancer.
Topics: Adult; Carcinoma, Endometrioid; Embryo Transfer; Endometrial Neoplasms; Female; Fertilization in Vitro; Humans; Intrauterine Devices; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Rate; Retrospective Studies | 2023 |
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |
Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Middle Aged; Pregnancy; Prospective Studies; Treatment Outcome; Young Adult | 2021 |
Optimal duration of fertility-sparing hormonal treatment for early-stage endometrioid endometrial cancer.
Topics: Adult; Carcinoma, Endometrioid; Drug Administration Schedule; Electronic Health Records; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Levonorgestrel; Republic of Korea; Retrospective Studies; Young Adult | 2021 |
Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer.
Topics: Administration, Oral; Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Retrospective Studies | 2017 |
Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Letrozole; Levonorgestrel; Nitriles; Retrospective Studies; Triazoles; Young Adult | 2017 |
Malignant endometrial polyp in woman with the levonorgestrel intrauterine system - a case report.
Topics: Asymptomatic Diseases; Biopsy; Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Polyps; Ultrasonography | 2019 |
Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies | 2019 |
Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Middle Aged; Pilot Projects; Prospective Studies; Treatment Outcome | 2019 |
Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Prospective Studies; Remission Induction; Treatment Outcome | 2013 |
Nonsurgical treatment of endometrial hyperplasia: is the road less traveled the one we should be taking more?
Topics: Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Minimally Invasive Surgical Procedures; Obesity; Progestins | 2013 |
Development of endometrioid adenocarcinoma despite Levonorgestrel-releasing intrauterine system: a case report with discussion and review of the RCOG/BSGE Guideline on the Management of Endometrial Hyperplasia.
Topics: Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Obesity, Morbid; Ovariectomy; Practice Guidelines as Topic; Risk Factors; Treatment Outcome | 2017 |
A case of endometrial carcinoma in a long-term Levonorgestrel Intrauterine System (LNG 52 mg-IUS) user.
Topics: Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Uterine Hemorrhage | 2017 |
Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2011 |
Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Intrauterine Devices, Medicated; Leuprolide; Levonorgestrel; Neoplasm Staging; Pregnancy; Remission Induction; Term Birth | 2013 |